{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T00:17:23Z","timestamp":1695514643690},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2012,12,10]],"date-time":"2012-12-10T00:00:00Z","timestamp":1355097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,12,10]],"date-time":"2012-12-10T00:00:00Z","timestamp":1355097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1038\/bmt.2012.240","type":"journal-article","created":{"date-parts":[[2012,12,10]],"date-time":"2012-12-10T11:45:03Z","timestamp":1355139903000},"page":"854-858","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["TLI in refractory chronic GVHD"],"prefix":"10.1038","volume":"48","author":[{"given":"R","family":"Devillier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Castagna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Gonzague","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"El-Cheikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"F\u00fcrst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Faucher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Michel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Blaise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,12,10]]},"reference":[{"key":"BFbmt2012240_CR1","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1053\/bbmt.2003.50026","volume":"9","author":"SJ Lee","year":"2003","unstructured":"Lee SJ, Vogelsang G, Flowers ME . Chronic graft-versus-host disease. Biol Blood Marrow Transplant 2003; 9: 215\u2013233.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2012240_CR2","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1182\/blood.V73.6.1720.1720","volume":"73","author":"KM Sullivan","year":"1989","unstructured":"Sullivan KM, Weiden PL, Storb R, Witherspoon RP, Fefer A, Fisher L et al. Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia. Blood 1989; 73: 1720\u20131728.","journal-title":"Blood"},{"key":"BFbmt2012240_CR3","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1056\/NEJM198106183042507","volume":"304","author":"PL Weiden","year":"1981","unstructured":"Weiden PL, Sullivan KM, Flournoy N, Storb R, Thomas ED . Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation. N Engl J Med 1981; 304: 1529\u20131533.","journal-title":"N Engl J Med"},{"key":"BFbmt2012240_CR4","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1056\/NEJM199907013410103","volume":"341","author":"G Socie","year":"1999","unstructured":"Socie G, Stone JV, Wingard JR, Weisdorf D, Henslee-Downey PJ, Bredeson C et al. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. N Engl J Med 1999; 341: 14\u201321.","journal-title":"N Engl J Med"},{"key":"BFbmt2012240_CR5","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V72.2.555.555","volume":"72","author":"KM Sullivan","year":"1988","unstructured":"Sullivan KM, Witherspoon RP, Storb R, Deeg HJ, Dahlberg S, Sanders JE et al. Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease. Blood 1988; 72: 555\u2013561.","journal-title":"Blood"},{"key":"BFbmt2012240_CR6","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1182\/blood.V97.5.1219","volume":"97","author":"G Akpek","year":"2001","unstructured":"Akpek G, Zahurak ML, Piantadosi S, Margolis J, Doherty J, Davidson R et al. Development of a prognostic model for grading chronic graft-versus-host disease. Blood 2001; 97: 1219\u20131226.","journal-title":"Blood"},{"key":"BFbmt2012240_CR7","doi-asserted-by":"publisher","first-page":"153","DOI":"10.5045\/kjh.2011.46.3.153","volume":"46","author":"PJ Martin","year":"2011","unstructured":"Martin PJ, Inamoto Y, Carpenter PA, Lee SJ, Flowers ME . Treatment of chronic graft-versus-host disease: past, present and future. Korean J Hematol 2011; 46: 153\u2013163.","journal-title":"Korean J Hematol"},{"key":"BFbmt2012240_CR8","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/bmt.2009.76","volume":"44","author":"T Furlong","year":"2009","unstructured":"Furlong T, Martin P, Flowers ME, Carnevale-Schianca F, Yatscoff R, Chauncey T et al. Therapy with mycophenolate mofetil for refractory acute and chronic GVHD. Bone Marrow Transplant 2009; 44: 739\u2013748.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2012240_CR9","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/S1083-8791(00)70026-7","volume":"6","author":"F Carnevale-Schianca","year":"2000","unstructured":"Carnevale-Schianca F, Martin P, Sullivan K, Flowers M, Gooley T, Anasetti C et al. Changing from cyclosporine to tacrolimus as salvage therapy for chronic graft-versus-host disease. Biol Blood Marrow Transplant 2000; 6: 613\u2013620.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2012240_CR10","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1053\/bbmt.2001.v7.pm11669216","volume":"7","author":"G Akpek","year":"2001","unstructured":"Akpek G, Lee SM, Anders V, Vogelsang GB . A high-dose pulse steroid regimen for controlling active chronic graft-versus-host disease. Biol Blood Marrow Transplant 2001; 7: 495\u2013502.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2012240_CR11","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1182\/blood-2006-01-0233","volume":"108","author":"C Cutler","year":"2006","unstructured":"Cutler C, Miklos D, Kim HT, Treister N, Woo SB, Bienfang D et al. Rituximab for steroid-refractory chronic graft-versus-host disease. Blood 2006; 108: 756\u2013762.","journal-title":"Blood"},{"key":"BFbmt2012240_CR12","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1182\/blood-2009-02-204750","volume":"114","author":"L Magro","year":"2009","unstructured":"Magro L, Mohty M, Catteau B, Coiteux V, Chevallier P, Terriou L et al. Imatinib mesylate as salvage therapy for refractory sclerotic chronic graft-versus-host disease. Blood 2009; 114: 719\u2013722.","journal-title":"Blood"},{"key":"BFbmt2012240_CR13","first-page":"75","volume":"11","author":"EO Bullorsky","year":"1993","unstructured":"Bullorsky EO, Shanley CM, Stemmelin GR, Musso A, Rabinovich O, Ceresetto J et al. Total lymphoid irradiation for treatment of drug resistant chronic GVHD. Bone Marrow Transplant 1993; 11: 75\u201376.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2012240_CR14","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1097\/00007890-199003000-00038","volume":"49","author":"G Socie","year":"1990","unstructured":"Socie G, Devergie A, Cosset JM, Pierga JY, Esperou H, Girinski T et al. Low-dose (one gray) total-lymphoid irradiation for extensive, drug-resistant chronic graft-versus-host disease. Transplantation 1990; 49: 657\u2013658.","journal-title":"Transplantation"},{"key":"BFbmt2012240_CR15","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","volume":"18","author":"H Glucksberg","year":"1974","unstructured":"Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295\u2013304.","journal-title":"Transplantation"},{"key":"BFbmt2012240_CR16","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","volume":"11","author":"AH Filipovich","year":"2005","unstructured":"Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945\u2013956.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2012240_CR17","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1182\/blood.V100.2.406","volume":"100","author":"SJ Lee","year":"2002","unstructured":"Lee SJ, Klein JP, Barrett AJ, Ringden O, Antin JH, Cahn JY et al. Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse. Blood 2002; 100: 406\u2013414.","journal-title":"Blood"},{"key":"BFbmt2012240_CR18","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/sj.bmt.1705490","volume":"38","author":"SZ Pavletic","year":"2006","unstructured":"Pavletic SZ, Lee SJ, Socie G, Vogelsang G . Chronic graft-versus-host disease: implications of the National Institutes of Health consensus development project on criteria for clinical trials. Bone Marrow Transplant 2006; 38: 645\u2013651.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2012240_CR19","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P . Nonparametric estimation from incomplete observations. J Amer Statist Assn 1958; 53: 457\u2013481.","journal-title":"J Amer Statist Assn"},{"key":"BFbmt2012240_CR20","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/0002-9343(80)90380-0","volume":"69","author":"HM Shulman","year":"1980","unstructured":"Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204\u2013217.","journal-title":"Am J Med"},{"key":"BFbmt2012240_CR21","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/bmt.2009.238","volume":"45","author":"SA Mitchell","year":"2010","unstructured":"Mitchell SA, Leidy NK, Mooney KH, Dudley WN, Beck SL, LaStayo PC et al. Determinants of functional performance in long-term survivors of allogeneic hematopoietic stem cell transplantation with chronic graft-versus-host disease (cGVHD). Bone Marrow Transplant 2010; 45: 762\u2013769.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2012240_CR22","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1097\/01.tp.0000173436.99153.78","volume":"80","author":"M Robin","year":"2005","unstructured":"Robin M, Guardiola P, Girinsky T, Hernandez G, Esperou H, Ribaud P et al. Low-dose thoracoabdominal irradiation for the treatment of refractory chronic graft-versus-host disease. Transplantation 2005; 80: 634\u2013642.","journal-title":"Transplantation"},{"key":"BFbmt2012240_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbmt.2010.05.011","volume":"17","author":"D Wolff","year":"2011","unstructured":"Wolff D, Schleuning M, von HS, Bacher U, Gerbitz A, Stadler M et al. Consensus Conference on Clinical Practice in Chronic GVHD: second-line treatment of chronic graft-versus-host disease. Biol Blood Marrow Transplant 2011; 17: 1\u201317.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2012240_CR24","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/bmt.2008.12","volume":"41","author":"M Mohty","year":"2008","unstructured":"Mohty M, Marchetti N, El-Cheikh J, Faucher C, Furst S, Blaise D . Rituximab as salvage therapy for refractory chronic GVHD. Bone Marrow Transplant 2008; 41: 909\u2013911.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2012240_CR25","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/ajh.20752","volume":"82","author":"A Busca","year":"2007","unstructured":"Busca A, Locatelli F, Marmont F, Ceretto C, Falda M . Recombinant human soluble tumor necrosis factor receptor fusion protein as treatment for steroid refractory graft-versus-host disease following allogeneic hematopoietic stem cell transplantation. Am J Hematol 2007; 82: 45\u201352.","journal-title":"Am J Hematol"},{"key":"BFbmt2012240_CR26","first-page":"1438","volume":"91","author":"H de Lavallade","year":"2006","unstructured":"de Lavallade H, Mohty M, Faucher C, Furst S, El-Cheikh J, Blaise D . Low-dose methotrexate as salvage therapy for refractory graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation. Haematologica 2006; 91: 1438\u20131440.","journal-title":"Haematologica"},{"key":"BFbmt2012240_CR27","doi-asserted-by":"publisher","first-page":"4255","DOI":"10.1200\/JCO.2007.10.8456","volume":"25","author":"DA Jacobsohn","year":"2007","unstructured":"Jacobsohn DA, Chen AR, Zahurak M, Piantadosi S, Anders V, Bolanos-Meade J et al. Phase II study of pentostatin in patients with corticosteroid-refractory chronic graft-versus-host disease. J Clin Oncol 2007; 25: 4255\u20134261.","journal-title":"J Clin Oncol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2012240.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2012240","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2012240.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T15:17:04Z","timestamp":1648048624000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2012240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,10]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["BFbmt2012240"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2012.240","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,10]]},"assertion":[{"value":"21 November 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}